Metabolism of endocannabinoids

Area of Science:

• Biochemistry
• Neuroscience
• Molecular Biology

Background:

• Endocannabinoids are endogenous lipid mediators derived from fatty acids.
• They act as ligands for cannabinoid receptors (CB1, CB2), TRPV1, and GPR55.
• Key endocannabinoids include anandamide (AEA) and 2-arachidonoylglycerol (2-AG), found widely in organisms, especially the brain.

Purpose of the Study:

• To review the synthesis and degradation pathways of AEA and 2-AG.
• To elucidate the mechanisms of endocannabinoid action via receptor-dependent and independent pathways.
• To highlight the biological significance of endocannabinoid metabolites.

Main Methods:

• Review of existing literature on endocannabinoid synthesis and degradation.
• Analysis of enzymatic pathways involved in endocannabinoid metabolism (e.g., phospholipases, DAGL, FAAH, MAGL).
• Examination of receptor binding affinities and downstream signaling effects.

Main Results:

• AEA is synthesized from phospholipids via N-arachidonoyl phosphatidylethanolamine hydrolysis.
• 2-AG is primarily formed from phosphatidylinositol hydrolysis by DAGL.
• Both AEA and 2-AG activate CB1 and CB2 receptors, with 2-AG showing higher affinity; they also influence metabolism through receptor-dependent and independent routes.
• Degradation occurs via enzymes like FAAH (for AEA) and MAGL (for 2-AG), and oxidative pathways (COX-2, LOX, CYP450).

Conclusions:

• Endocannabinoids (AEA, 2-AG) are synthesized from membrane phospholipids and degraded by specific enzymes.
• They play vital roles in regulating cellular metabolism through receptor activation and other mechanisms.
• Metabolites of endocannabinoids also possess significant biological activity.